- Home
- IMVT vs GATX Comparison
IMVT vs GATX Comparison
Compare IMVT & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMVT | GATX |
|---|---|---|
| Founded | 2018 | 1898 |
| Country | United States | United States |
| Employees | 362 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.2B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IMVT | GATX |
|---|---|---|
| Price | $26.46 | $178.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $30.78 | ★ $215.00 |
| AVG Volume (30 Days) | ★ 1.2M | 185.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ 17.22 |
| EPS | N/A | ★ 9.12 |
| Revenue | N/A | ★ $1,740,400,000.00 |
| Revenue This Year | N/A | $42.09 |
| Revenue Next Year | N/A | $3.32 |
| P/E Ratio | ★ N/A | $19.96 |
| Revenue Growth | N/A | ★ 9.77 |
| 52 Week Low | $12.72 | $139.44 |
| 52 Week High | $29.25 | $199.00 |
Technical Indicators
Market Signals| Indicator | IMVT | GATX |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 37.65 |
| Support Level | $24.63 | $168.23 |
| Resistance Level | $27.71 | $186.61 |
| Average True Range (ATR) | 1.07 | 5.25 |
| MACD | -0.05 | -1.89 |
| Stochastic Oscillator | 26.02 | 9.31 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.